MIM
IBB icon

Moseley Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Moseley Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,341
Closed -$219K – 178
2021
Q2 		$219K Buy
+1,341
New +$207K 0.11% 167
2020
Q2 		– Sell
-1,925
Closed -$207K – 133
2020
Q1 		$207K Buy
+1,925
New +$222K 0.24% 110

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Moseley Investment Management's IBB Position: Q3 2021 in Review

Moseley Investment Management sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 1,341 shares — an estimated $219K sold.

Moseley Investment Management first reported a position in IBB in Q1 2020 and held it in 2 quarters. The position peaked at $219K in Q2 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Moseley Investment Management reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Moseley Investment Management sold 1,341 iShares Biotechnology ETF shares in Q3 2021, an estimated $219K.
  • Moseley Investment Management first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 2 quarters.
  • Moseley Investment Management's iShares Biotechnology ETF position peaked at $219K in Q2 2021.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Moseley Investment Management's 13F filing for Q3 2021, filed 27 Oct 2021.